Clinical Trial Update: A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating dotinurad in gout patients who are intolerant to XOI or who have uricase failure; the study status is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• Dotinurad (dotinurad)

Snippet

Sponsor: Crystalys Therapeutics | Conditions: Gout | Phase 2 | Status: NOT_YET_RECRUITING